Advertisement RNL opens stem cell medical center in China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RNL opens stem cell medical center in China

South Korean adult stem cell company RNL Bio has opened a stem cell medical center in Beijing's Yanda International Medical Research Institute.

The facility, spread over 41,600 ft² of the research institute, has a capacity to store stem cells of 20,000 patients.

Under the partnership with Yanda Group, RNL will take up the charge of stem cell storage in the GMP facility and management of medical treatment.

The clinical research and treatment of patients by stem cell therapy will be administered by Yanda Group.

RNL Stem Cell Institute president Jeong Chan Ra said through the stem cell treatment in China, the company hopes to offer broader opportunities to patients with incurable diseases.